Leprostatics

Leprostatics are anti-infective agents that inhibit the growth of Mycobacterium leprae, the bacteria that causes leprosy. Here is the latest research on leprostatics.

February 19, 2020

Efficacy of topical epigallocatechin gallate (EGCG) 1% on the healing of chronic plantar ulcers in leprosy

The Journal of Dermatological Treatment
C R S PrakoeswaM Y Listiawan
December 17, 2019

WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Jong-Hoon ParkYasuhiko Suzuki
April 28, 2020
Review

Metabolism and interactions of antileprosy drugs

Biochemical Pharmacology
Joseph George
August 20, 2019
Case Report
Open Access

Crossing to Safety

The American Journal of Tropical Medicine and Hygiene
Claire Panosian Dunavan
April 26, 2020

Brevipalpus Species Vectoring Citrus Leprosis Virus (Cilevirus and Dichorhavirus)

Journal of Economic Entomology
Leticia M FerreiraValdenice M Novelli
September 8, 2019
Review

Diet and nutrition: An important risk factor in leprosy

Microbial Pathogenesis
Ved Prakash DwivediDebprasad Chattopadhyay
December 28, 2019

Transcription initiation in mycobacteria: a biophysical perspective

Transcription
Hande BoyaciElizabeth A Campbell
September 12, 2019
Comment / Editorial

De novo histoid leprosy - Further points of focus

Revista Da Sociedade Brasileira De Medicina Tropical
Sajitha Venkatesan, Pugazhenthan Thangaraju
December 1, 2019
Open Access

Ulcers in leprosy patients, an unrecognized clinical manifestation: a report of 8 cases

BMC Infectious Diseases
Denis MiyashiroMaria Angela Bianconcini Trindade
September 7, 2019
Open Access

Geographic and socioeconomic factors associated with leprosy treatment default: An analysis from the 100 Million Brazilian Cohort

PLoS Neglected Tropical Diseases
Kaio Vinicius Freitas de AndradeGerson Oliveira Penna
July 10, 2019
Open Access

Development of Inhibitors against Mycobacterium abscessus tRNA (m1 G37) Methyltransferase (TrmD) Using Fragment-Based Approaches

Journal of Medicinal Chemistry
Andrew J WhitehouseAnthony G Coyne
July 1, 2020
Open Access

Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification

Nucleic Acids Research
Sherine E ThomasVítor Mendes
October 18, 2019

Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients

Emerging Microbes & Infections
Santosh ChokkakulaHongsheng Wang
June 6, 2019
Preprint
Open Access

EPIDEMIOLOGICAL AND SPACE ASPECTS OF THE SCHOOLS OF THE NATIONAL LEPROSY CAMPAIGN: the case of Sobral – Ceará

BioRxiv : the Preprint Server for Biology
Vitória Ferreira do AmaralAna Suelen Pedroza Cavalcante
January 25, 2020
Review

Prevention of transmission of leprosy: The current scenario

Indian Journal of Dermatology, Venereology and Leprology
Aparna Palit, Hemanta Kumar Kar
January 28, 2020

Type 2 leprosy reaction resembling Sweet syndrome: Review of new and published cases

The Australasian Journal of Dermatology
Sonia Chavez-AlvarezMinerva Gomez-Flores
July 14, 2020
Open Access

Citrus Leprosis Virus C Encodes Three Proteins With Gene Silencing Suppression Activity

Frontiers in Microbiology
Mikhail Oliveira LeastroJesús Ángel Sánchez-Navarro
January 24, 2020
Open Access

Incidence of Citrus leprosis virus C and Orchid fleck dichorhavirus Citrus Strain in Mites of the Genus Brevipalpus in Mexico

Journal of Economic Entomology
Ana Karen Beltran-BeltranPedro L Robles-García
June 27, 2019

IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells

The Journal of Immunology : Official Journal of the American Association of Immunologists
David I WeissRobert L Modlin
September 4, 2019
Open Access

Leprosy in elderly people and the profile of a retrospective cohort in an endemic region of the Brazilian Amazon

PLoS Neglected Tropical Diseases
João Sérgio de Sousa OliveiraMarília Brasil Xavier

Sign up to follow this feed and discover related papers.

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2020 Meta ULC. All rights reserved
/feed-previews/leprostatics/2305d2b1-b748-4e65-8431-8cbc2f27487a